[1]
Moksnes KM,Ilner SO, Electroconvulsive therapy--efficacy and side-effects. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2010 Dec 16;
[PubMed PMID: 21164584]
[2]
Payne NA,Prudic J, Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. Journal of psychiatric practice. 2009 Sep
[PubMed PMID: 19820553]
Level 3 (low-level) evidence
[3]
Kadiyala PK,Kadiyala LD, Anaesthesia for electroconvulsive therapy: An overview with an update on its role in potentiating electroconvulsive therapy. Indian journal of anaesthesia. 2017 May;
[PubMed PMID: 28584345]
Level 3 (low-level) evidence
[4]
Gaines GY 3rd,Rees DI, Anesthetic considerations for electroconvulsive therapy. Southern medical journal. 1992 May;
[PubMed PMID: 1585198]
[5]
Petrides G,Fink M,Husain MM,Knapp RG,Rush AJ,Mueller M,Rummans TA,O'Connor KM,Rasmussen KG Jr,Bernstein HJ,Biggs M,Bailine SH,Kellner CH, ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. The journal of ECT. 2001 Dec;
[PubMed PMID: 11731725]
[6]
Baghai TC,Möller HJ, Electroconvulsive therapy and its different indications. Dialogues in clinical neuroscience. 2008;
[PubMed PMID: 18472488]
[7]
Warneke L, Managing resistant depression. When patients do not respond to therapy. Canadian family physician Medecin de famille canadien. 1993 Apr;
[PubMed PMID: 8495142]
[8]
Strassnig M,Riedel M,Müller N, Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive Disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2004 Jul;
[PubMed PMID: 15346542]
[9]
Regenold WT,Weintraub D,Taller A, Electroconvulsive therapy for epilepsy and major depression. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 1998 Spring;
[PubMed PMID: 9581214]
[10]
Fregni F,Simon DK,Wu A,Pascual-Leone A, Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. Journal of neurology, neurosurgery, and psychiatry. 2005 Dec;
[PubMed PMID: 16291882]
Level 1 (high-level) evidence
[11]
Taylor S, Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. Southern medical journal. 2007 May;
[PubMed PMID: 17534086]
[12]
Buday J,Albrecht J,Mareš T,Podgorná G,Horáčková K,Kališová L,Raboch J,Anders M, Brain Tumors and Electroconvulsive Therapy: A Literature Overview of the Last 80 Years. Frontiers in neurology. 2020;
[PubMed PMID: 32849199]
Level 3 (low-level) evidence
[13]
Pandya M,Pozuelo L,Malone D, Electroconvulsive therapy: what the internist needs to know. Cleveland Clinic journal of medicine. 2007 Sep;
[PubMed PMID: 17879522]
[14]
Chanpattana W,Kojima K,Kramer BA,Intakorn A,Sasaki S,Kitphati R, ECT practice in Japan. The journal of ECT. 2005 Sep;
[PubMed PMID: 16127301]
[15]
Jindal S,Sidhu GK,Kumari S,Kamboj P,Chauhan R, Etomidate versus Propofol for Motor Seizure Duration during Modified Electroconvulsive Therapy. Anesthesia, essays and researches. 2020 Jan-Mar;
[PubMed PMID: 32843794]
[16]
Wojdacz R,Święcicki Ł,Antosik-Wójcińska A, Comparison of the effect of intravenous anesthetics used for anesthesia during electroconvulsive therapy on the hemodynamic safety and the course of ECT. Psychiatria polska. 2017 Dec 30;
[PubMed PMID: 29432502]
[17]
Avramov MN,Husain MM,White PF, The comparative effects of methohexital, propofol, and etomidate for electroconvulsive therapy. Anesthesia and analgesia. 1995 Sep;
[PubMed PMID: 7653829]
Level 2 (mid-level) evidence
[18]
Martone CH,Nagelhout J,Wolf SM, Methohexital: a practical review for outpatient dental anesthesia. Anesthesia progress. 1991 Nov-Dec;
[PubMed PMID: 1842156]
[19]
Gazdag G,Kocsis N,Tolna J,Iványi Z, Etomidate versus propofol for electroconvulsive therapy in patients with schizophrenia. The journal of ECT. 2004 Dec;
[PubMed PMID: 15591855]
[20]
Upchurch CP,Grijalva CG,Russ S,Collins SP,Semler MW,Rice TW,Liu D,Ehrenfeld JM,High K,Barrett TW,McNaughton CD,Self WH, Comparison of Etomidate and Ketamine for Induction During Rapid Sequence Intubation of Adult Trauma Patients. Annals of emergency medicine. 2017 Jan;
[PubMed PMID: 27993308]
[22]
Shah PJ,Dubey KP,Watti C,Lalwani J, Effectiveness of thiopentone, propofol and midazolam as an ideal intravenous anaesthetic agent for modified electroconvulsive therapy: A comparative study. Indian journal of anaesthesia. 2010 Jul;
[PubMed PMID: 20882170]
Level 2 (mid-level) evidence
[23]
Hooten WM,Rasmussen KG Jr, Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. The journal of ECT. 2008 Sep;
[PubMed PMID: 18628717]
Level 1 (high-level) evidence
[24]
Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate CA Jr, Gould TD. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological reviews. 2018 Jul:70(3):621-660. doi: 10.1124/pr.117.015198. Epub
[PubMed PMID: 29945898]
[25]
Jankauskas V,Necyk C,Chue J,Chue P, A review of ketamine's role in ECT and non-ECT settings. Neuropsychiatric disease and treatment. 2018;
[PubMed PMID: 29922060]
[26]
Aoki N,Suwa T,Kawashima H,Tajika A,Sunada N,Shimizu T,Murai T,Kinoshita T,Takekita Y, Sevoflurane in electroconvulsive therapy: A systematic review and meta-analysis of randomised trials. Journal of psychiatric research. 2021 Sep;
[PubMed PMID: 34171759]
Level 1 (high-level) evidence
[27]
Pekel M,Postaci NA,Aytaç İ,Karasu D,Keleş H,Şen Ö,Dikmen B,Göka E, Sevoflurane versus propofol for electroconvulsive therapy: effects on seizure parameters, anesthesia recovery, and the bispectral index. Turkish journal of medical sciences. 2016 Apr 19;
[PubMed PMID: 27513252]
[28]
Andrade C,Shah N,Tharyan P,Reddy MS,Thirunavukarasu M,Kallivayalil RA,Nagpal R,Bohra NK,Sharma A,Mohandas E, Position statement and guidelines on unmodified electroconvulsive therapy. Indian journal of psychiatry. 2012 Apr;
[PubMed PMID: 22988318]
[29]
Marsch SC,Steiner L,Bucher E,Pargger H,Schumann M,Aebi T,Hunziker PR,Siegemund M, Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial. Critical care (London, England). 2011 Aug 16;
[PubMed PMID: 21846380]
Level 1 (high-level) evidence
[30]
Hill GE,Wong KC,Hodges MR, Lithium carbonate and neuromuscular blocking agents. Anesthesiology. 1977 Feb;
[PubMed PMID: 835845]
[31]
Soriano SG,Martyn JA, Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance. Clinical pharmacokinetics. 2004;
[PubMed PMID: 14748617]
[32]
Devanand DP,Decina P,Sackeim HA,Prudic J, Status epilepticus following ECT in a patient receiving theophylline. Journal of clinical psychopharmacology. 1988 Apr;
[PubMed PMID: 3372714]
[33]
Yeoh TY,Manninen P,Kalia SK,Venkatraghavan L, Anesthesia considerations for patients with an implanted deep brain stimulator undergoing surgery: a review and update. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 2017 Mar;
[PubMed PMID: 28028671]
[34]
MacPherson RD,Loo CK,Barrett N, Electroconvulsive therapy in patients with cardiac pacemakers. Anaesthesia and intensive care. 2006 Aug;
[PubMed PMID: 16913344]
[35]
Payne NA,Prudic J, Electroconvulsive therapy: Part II: a biopsychosocial perspective. Journal of psychiatric practice. 2009 Sep
[PubMed PMID: 19820554]
Level 3 (low-level) evidence
[36]
Ray AK, How bad was unmodified electroconvulsive therapy! A retrospective study. Indian journal of psychiatry. 2016 Apr-Jun;
[PubMed PMID: 27385857]
Level 2 (mid-level) evidence